The role of PAX2 in normal and abnormal development of the urinary tract

被引:49
作者
Eccles, MR [1 ]
机构
[1] Univ Otago, Dept Biochem, Canc Genet Lab, Dunedin, New Zealand
关键词
PAX2; PAX genes; kidney development; urogenital tract; Wilms tumor; vesicoureteric reflux; multicystic dysplasic kidney;
D O I
10.1007/s004670050533
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The molecular etiology of many urinary tract abnormalities in children remains unknown, but a number of genes with a key role in urogenital development have now been identified. PAX2, one such gene, encodes a transcription factor which is critically required for epithelial differentiation within the urogenital tract. Recent studies suggest that PAX2 mutations lead to urological abnormalities and renal failure, while overexpression of PAX2 in the kidneys of mice causes multifocal microcystic tubular dilatation. In humans persistent PAX2 expression has been identified in multicystic dysplastic kidneys. In this review, recent research on the developmental gene, PAX2, and its involvement in normal and abnormal kidney development is summarized. In addition, an overview of the phenotypes associated with either loss-of-function PAX2 mutations or PAX2 overexpression is presented. A brief summary of factors that are known to regulate PAX2 and genes that may be regulated by PAX2 protein is also included.
引用
收藏
页码:712 / 720
页数:9
相关论文
共 62 条
  • [1] BAILEY RR, 1979, REFLUX NEPHROPATHY, P3
  • [2] BECKWITH J B, 1990, Pediatric Pathology, V10, P1
  • [3] Chamberlin HM, 1997, DEVELOPMENT, V124, P3919
  • [4] VESICOURETERIC REFLUX - SEGREGATION ANALYSIS
    CHAPMAN, CJ
    BAILEY, RR
    JANUS, ED
    ABBOTT, GD
    LYNN, KL
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1985, 20 (04): : 577 - 584
  • [5] Absence of PAX2 gene mutations in patients with primary familial vesicoureteric reflux
    Choi, KL
    McNoe, LA
    French, MC
    Guilford, PJ
    Eccles, MR
    [J]. JOURNAL OF MEDICAL GENETICS, 1998, 35 (04) : 338 - 339
  • [6] COLODNY AH, 1987, PEDIATR CLIN N AM, V34, P1365
  • [7] The prevalence of PAX2 mutations in patients with isolated colobomas or colobomas associated with urogenital anomalies
    Cunliffe, HE
    McNoe, LA
    Ward, TA
    Devriendt, K
    Brunner, HG
    Eccles, MR
    [J]. JOURNAL OF MEDICAL GENETICS, 1998, 35 (10) : 806 - 812
  • [8] Pax genes and organogenesis
    Dahl, E
    Koseki, H
    Balling, R
    [J]. BIOESSAYS, 1997, 19 (09) : 755 - 765
  • [9] Dehbi M, 1996, ONCOGENE, V13, P447
  • [10] C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8
    Dorfler, P
    Busslinger, M
    [J]. EMBO JOURNAL, 1996, 15 (08) : 1971 - 1982